Vanguard Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Vanguard Asset Management's DGX Position: Q2 2026 in Review
Vanguard Asset Management increased its Quest Diagnostics (DGX) stake by 12% in Q2 2026, buying an estimated $5.18M and bringing the position to 253,146 shares worth $53.7M. The position accounts for 0.04% of the portfolio, ranked #391.
Vanguard Asset Management first reported a position in DGX in Q1 2026 and has held it in 2 quarters since. 1,046 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Vanguard Asset Management held 253,146 shares of Quest Diagnostics worth $53.7M as of Q2 2026.
- Vanguard Asset Management bought 26,416 Quest Diagnostics shares in Q2 2026, an estimated $5.18M.
- Quest Diagnostics made up 0.04% of Vanguard Asset Management's portfolio in Q2 2026, its #391 holding.
- Vanguard Asset Management first reported a position in Quest Diagnostics in Q1 2026 and has held it in 2 quarters since.
- 1,046 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.